What is BARDA DRIVe?

In 2019, the Biomedical Advanced Research and Development Authority (BARDA) expanded their Division of Research, Innovation, and Ventures (DRIVe) to stimulate investment and innovation in health security products and technologies. DRIVe provides technical and financial resources to entrepreneurs whose ideas have the potential to transform emergency preparedness, detection, and response.

Biolocity was selected as one of 13 sites in the DRIVe accelerator network to identify inventors and connect them with resources that will enable earlier treatment and warning for communities against outbreaks.

 Drive Network
BARDA EZ-BAA 

DRIVe accelerates the development of new innovations and approaches that solve health security challenges and protect Americans from health security threats. Below are the current areas of interest for funding and partnership in the EZ-BAA.

  • Lab at Home: On-demand, at-home detection of biochemical health markers to enable diagnostics.
  • Digital MCMs: Empowering people to respond to health security threats through rapidly deployable digital health tools.
  • Healing Lungs: Simpler, safer lung support for ARDS patients.
  • ReBooT: Repurposing drugs for biological threats.
  • RePAIR: Repurposing and advancing innovations against Rad/Nuc threats.
  • AGNOSTIC DIAGNOSTICS: A next-generation sequencing-based diagnostic test to identify any and every pathogen from a single sample.
  • ImmuneChip+: Advancing multi-organ tissue chips.

Up to $749,000 in funding is available per technology with a required 30% cost share. Solicitation Details Here

The Biolocity team can assist potential applicants in submitting a robust and on-target proposal. If you are interested in learning how we can help with your submission, please request a technology review meeting.

Request Meeting Here